QuidelOrtho (QDEL)

• Market cap: $2.05B
• 1 day: -3.84%
• 5 days: 2.09%
• 1 month: -2.03%
• 3 months: 12.75%
• 6 months: -31.99%
• Year to date: -32.64%
• 1 year: -3.62%
• 5 years: -87.06%
• 10 years: 28.56%
• Sector: Healthcare
• Industry: Medical Devices

About: QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.

Employees: 6,600

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

20% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 87

19% more call options, than puts

Call options by funds: $13.7M | Put options by funds: $11.6M

1.94% more ownership

Funds ownership: 108.95% [Q4 2024] → 110.89% (+1.94%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 6 [Q4 2024] → 6 (+0) [Q1 2025]

4% less funds holding

Funds holding: 272 [Q4 2024] → 261 (-11) [Q1 2025]

18% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 39

20% less capital invested

Capital invested by funds: $3.26B [Q4 2024] → $2.61B (-$652M) [Q1 2025]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $25 18% downside
• Avg. target: $33 8% upside
• High target: $44 45% upside

3 analyst ratings

• positive: 1 33%
• neutral: 1 33%
• negative: 1 33%

UBS Lu Li	4% downside $29	Neutral Maintained	8 May 2025
Jefferies Tycho Peterson	45% upside $44	Buy Upgraded	8 May 2025
JP Morgan Casey Woodring	18% downside $25	Underweight Maintained	21 Apr 2025